XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 38.26%113.75M | 65.81%116.67M | 77.30%105.59M | 67.52%84.72M | 66.67%82.27M | 78.71%70.37M | 64.68%59.56M | 4.24%50.57M | 220.24%49.36M | 352.85%39.37M |
Transactional financial assets | 18.13%60.89M | 1.73%53.08M | -0.56%51.72M | 0.75%52.29M | 11.57%51.54M | 30.73%52.17M | 33.48%52.02M | 142.73%51.9M | 301.37%46.2M | 233.58%39.91M |
Notes receivable and accounts receivable | 44.93%17.71M | 32.91%15.63M | 98.90%17.66M | 33.28%21.15M | 100.80%12.22M | 54.70%11.76M | 15.00%8.88M | 28.90%15.87M | -55.09%6.09M | -42.10%7.6M |
-Notes receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --500K | -50.00%150K |
-Accounts receivable | 44.93%17.71M | 32.91%15.63M | 98.90%17.66M | 33.28%21.15M | 118.77%12.22M | 57.81%11.76M | 17.28%8.88M | 28.90%15.87M | -58.78%5.59M | -41.92%7.45M |
Other receivables (including interest and dividends) | 74.38%6M | -3.27%3.36M | 36.37%4.32M | 52.30%5.29M | 13.31%3.44M | 12.62%3.48M | 73.19%3.17M | 95.03%3.47M | 27.36%3.04M | 18.28%3.09M |
-Other receivable | ---- | -3.27%3.36M | ---- | ---- | ---- | 12.62%3.48M | ---- | 95.03%3.47M | ---- | 18.28%3.09M |
Contractual assets | -10.30%26.36M | -10.54%24.9M | -40.62%15.89M | -6.39%19.47M | 27.37%29.38M | 27.11%27.83M | 38.83%26.75M | 54.00%20.8M | 69.60%23.07M | 45.17%21.89M |
Inventories | 2.53%652.34K | -11.38%546.14K | -13.27%536.07K | -15.35%528.31K | 6.44%636.22K | 4.87%616.25K | 9.61%618.08K | 32.77%624.15K | 43.63%597.75K | 18.16%587.66K |
Receivable financing | --5.7K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other current assets | --1.78M | --1.95M | 305.25%1.66M | 288.90%4.01M | ---- | ---- | -93.43%410.85K | -84.75%1.03M | -96.85%230.41K | -20.11%6.37M |
Total current assets | 26.54%227.14M | 30.03%216.14M | 30.37%197.39M | 29.93%187.45M | 39.60%179.5M | 39.89%166.22M | 36.68%151.4M | 37.75%144.27M | 100.29%128.58M | 97.82%118.83M |
Non Current assets | ||||||||||
Other non-current financial assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -90.60%3.17M | -89.78%3.14M |
Fixed assets | ---- | 25.50%80.68M | ---- | ---- | ---- | -4.24%64.28M | ---- | -4.37%65.81M | ---- | -4.35%67.13M |
Constru in process | ---- | -92.97%1.55M | ---- | ---- | ---- | 140.86%22.04M | ---- | 815.64%20.27M | ---- | 158.98%9.15M |
Intangible assets | -2.74%5M | -2.72%5.04M | -2.70%5.07M | -2.68%5.11M | -2.67%5.14M | -2.65%5.18M | -2.63%5.21M | -2.61%5.25M | -2.60%5.28M | -2.58%5.32M |
Goodwill | 0.00%406.21K | 0.00%406.21K | 0.00%406.21K | 0.00%406.21K | 0.00%406.21K | 0.00%406.21K | 0.00%406.21K | 0.00%406.21K | 0.00%406.21K | 0.00%406.21K |
Long deferred expense | 114.38%4.76M | 113.69%4.92M | 113.06%5.09M | 112.46%5.25M | -13.23%2.22M | -12.81%2.3M | -12.41%2.39M | -12.04%2.47M | 32.60%2.56M | 32.96%2.64M |
Deferred tax assets | --768.26K | --768.26K | --768.26K | --768.26K | ---- | ---- | ---- | ---- | -18.50%51.12K | -18.50%51.12K |
Usufruct assets | --3.07M | --3.07M | --3.07M | --3.07M | ---- | ---- | ---- | ---- | ---- | ---- |
Other non current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --110.44K | ---- | ---- |
Total non current assets | -5.59%96.19M | 2.36%96.43M | 3.17%97.72M | 4.98%99.02M | 13.25%101.89M | 7.26%94.21M | 15.43%94.72M | 13.94%94.32M | -21.66%89.97M | -21.81%87.83M |
Total assets | 14.91%323.33M | 20.02%312.57M | 19.90%295.11M | 20.07%286.47M | 28.75%281.39M | 26.02%260.43M | 27.63%246.12M | 27.24%238.59M | 22.06%218.55M | 19.87%206.66M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Notes payable and accounts payable | -22.59%51.24M | -4.61%53.52M | -14.19%46M | -7.02%52.52M | 42.79%66.19M | 25.68%56.11M | 27.63%53.61M | 30.17%56.48M | 12.63%46.36M | 7.64%44.64M |
-Notes payable | ---- | 375.00%4.75M | 370.50%4.71M | -20.00%800K | ---- | --1M | --1M | 733.33%1M | 733.33%1M | ---- |
-Accounts payable | -22.59%51.24M | -11.50%48.77M | -21.50%41.29M | -6.78%51.72M | 45.94%66.19M | 23.44%55.11M | 25.25%52.61M | 28.22%55.48M | 10.53%45.36M | 7.96%44.64M |
Contract liabilities | --17.86K | -85.78%17.86K | -12.74%109.6K | 328.07%109.6K | ---- | 83.38%125.6K | --125.6K | --25.6K | ---- | 82.06%68.5K |
Advance receipts | ---- | ---- | ---- | ---- | 318.68%125.6K | ---- | ---- | ---- | --30K | ---- |
Salaries payable | 102.32%1.43M | -46.88%712.58K | -33.79%732.9K | 8.21%1.92M | -1.42%705.73K | 110.34%1.34M | 105.85%1.11M | -1.60%1.77M | -13.51%715.9K | -17.19%637.76K |
Taxs payable | 6.80%26.52M | 6.84%26.5M | 7.26%27.18M | -0.77%25.85M | -6.01%24.83M | -2.96%24.8M | 3.82%25.34M | 8.63%26.05M | 10.77%26.42M | 9.52%25.56M |
Other payable (including interest and dividends) | 37.93%136.06M | 40.51%127.49M | 47.33%120.56M | 48.84%109.54M | 46.63%98.64M | 52.08%90.73M | 53.98%81.83M | 52.78%73.6M | 52.49%67.27M | 54.29%59.66M |
-Dividend payable | 0.00%291.46K | 0.00%291.46K | 0.00%291.46K | 0.00%291.46K | 0.00%291.46K | 0.00%291.46K | 0.00%291.46K | 0.00%291.46K | --291.46K | 0.00%291.46K |
-Other payable | ---- | 40.65%127.2M | ---- | ---- | ---- | 52.34%90.44M | ---- | 53.10%73.31M | ---- | 54.70%59.37M |
Non current liabilities due within one year | --103.93K | --103.93K | --103.93K | --103.93K | ---- | ---- | ---- | ---- | ---- | ---- |
Other current liabilities | --1.61K | --1.61K | --9.86K | --9.86K | ---- | ---- | ---- | ---- | ---- | ---- |
Total current liabilities | 13.06%215.37M | 20.36%208.34M | 20.17%194.69M | 20.34%190.05M | 35.30%190.49M | 32.58%173.1M | 34.83%162.01M | 34.58%157.93M | 28.05%140.79M | 25.20%130.56M |
Current liabilities | ||||||||||
Deferred tax liabilities | 19.44%3.19M | 19.44%3.19M | 19.44%3.19M | 19.44%3.19M | -8.09%2.67M | -8.09%2.67M | -5.94%2.67M | -5.94%2.67M | -3.08%2.9M | -3.08%2.9M |
Lease liabilities | --3.08M | --3.08M | --3.08M | --3.08M | ---- | ---- | ---- | ---- | ---- | ---- |
Total non current liabilities | 134.96%6.27M | 134.96%6.27M | 134.96%6.27M | 134.96%6.27M | -8.09%2.67M | -8.09%2.67M | -5.94%2.67M | -5.94%2.67M | -3.08%2.9M | -3.08%2.9M |
Total liabilities | 14.74%221.63M | 22.09%214.61M | 22.03%200.96M | 22.24%196.32M | 34.43%193.16M | 31.70%175.77M | 33.89%164.68M | 33.63%160.6M | 27.23%143.69M | 24.41%133.47M |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%374.98M | 0.00%374.98M | 0.00%374.98M | 0.00%374.98M | 0.00%374.98M | 0.00%374.98M | 0.00%374.98M | 0.00%374.98M | 0.00%374.98M | 0.00%374.98M |
Capital reserve funds | 0.00%367.1M | 0.00%367.1M | 0.00%367.1M | 0.00%367.1M | 0.00%367.1M | 0.00%367.1M | 0.00%367.1M | 0.00%367.1M | 0.00%367.1M | 0.00%367.1M |
Surplus reserve funds | 0.00%43.27M | 0.00%43.27M | 0.00%43.27M | 0.00%43.27M | 0.00%43.27M | 0.00%43.27M | 0.00%43.27M | 0.00%43.27M | 0.00%43.27M | 0.00%43.27M |
Retained profit | 1.94%-681.65M | 1.90%-685.39M | 1.81%-689.2M | 1.72%-693.19M | 1.89%-695.12M | 1.61%-698.69M | 1.63%-701.9M | 1.49%-705.35M | 1.22%-708.49M | 1.12%-710.15M |
Other composite income | 0.00%-2M | 0.00%-2M | 0.00%-2M | 0.00%-2M | 0.00%-2M | 0.00%-2M | 0.00%-2M | 0.00%-2M | 0.00%-2M | 0.00%-2M |
Shareholders equity without minority interests | 15.26%101.69M | 15.71%97.96M | 15.60%94.15M | 15.59%90.15M | 17.86%88.23M | 15.66%84.66M | 16.61%81.45M | 15.84%77.99M | 13.24%74.86M | 12.38%73.19M |
Total shareholder equity | 15.26%101.69M | 15.71%97.96M | 15.60%94.15M | 15.59%90.15M | 17.86%88.23M | 15.66%84.66M | 16.61%81.45M | 15.84%77.99M | 13.24%74.86M | 12.38%73.19M |
Total liabilityies and equity | 14.91%323.33M | 20.02%312.57M | 19.90%295.11M | 20.07%286.47M | 28.75%281.39M | 26.02%260.43M | 27.63%246.12M | 27.24%238.59M | 22.06%218.55M | 19.87%206.66M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.